Literature DB >> 26071133

Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis.

Mira M Wouters1, Sander Van Wanrooy1, Anh Nguyen2, James Dooley2, Javier Aguilera-Lizarraga1, Winde Van Brabant1, Josselyn E Garcia-Perez2, Lukas Van Oudenhove1, Marc Van Ranst3, Jan Verhaegen4, Adrian Liston2, Guy Boeckxstaens1.   

Abstract

OBJECTIVE: Psychological factors increase the risk to develop postinfectious IBS (PI-IBS), but the mechanisms involved are unclear. As stress affects the immune system, we investigated the potential interaction between psychological factors, the immune response against infectious gastroenteritis (IGE) and the development of IGE and PI-IBS in a large cohort exposed to contaminated drinking water.
DESIGN: 18 620 people exposed to contaminated drinking water (norovirus, Giardia lamblia, Campylobacter jejuni) were invited to participate in a prospective controlled cohort study. They were asked to complete questionnaires assessing demographic, psychological and clinical data during the outbreak and 1 year later. At both time points, in-depth immune function (peripheral blood and rectal biopsies) was studied in a subgroup of subjects.
RESULTS: 1379 subjects completed the questionnaires during the outbreak, of which 271 developed IGE. Risk factors for IGE included younger age, pre-existing dyspepsia-like symptoms, anxiety and drinking contaminated tap water. Anxiety scores before the outbreak inversely correlated with interleukin-2-expressing CD4+ T cells (r=0.6, p=0.01, n=23). At follow-up, 34 of 172 (20%) IGE subjects developed IBS compared with 24/366 exposed participants (7%, p<0.0001, χ(2) test). A Th2 cytokine phenotype at time of infection was associated with increased risk for PI-IBS 1 year later. Except for increased B cell numbers, no evidence for systemic or rectal mucosal immune activation in PI-IBS was demonstrated at follow-up.
CONCLUSIONS: Our study shows that the increased risk of patients with psychological comorbidity to develop PI-IBS may partly result from an increased susceptibility to develop IGE, possibly resulting from a Th2-immune bias. TRIAL REGISTRATION NUMBER: (ClinicalTrials.gov NCT01497847). Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  IGE; IRRITABLE BOWEL SYNDROME

Mesh:

Substances:

Year:  2015        PMID: 26071133     DOI: 10.1136/gutjnl-2015-309460

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

Review 1.  The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.

Authors:  Kerry Murphy; Caroline M Mitchell
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

Review 2.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

Review 3.  Post-Infectious Irritable Bowel Syndrome.

Authors:  Yeong Yeh Lee; Chandramouli Annamalai; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2017-09-25

4.  Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance.

Authors:  Geng Qin; Yu Zhang; Shu-Kun Yao
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

5.  Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome.

Authors:  Adam L Edwinson; Lu Yang; Stephanie Peters; Nikita Hanning; Patricio Jeraldo; Pratik Jagtap; Joshua B Simpson; Tzu-Yi Yang; Praveen Kumar; Subina Mehta; Asha Nair; Margaret Breen-Lyles; Lakshmikanth Chikkamenahalli; Rondell P Graham; Benedicte De Winter; Robin Patel; Surendra Dasari; Purna Kashyap; Timothy Griffin; Jun Chen; Gianrico Farrugia; Matthew R Redinbo; Madhusudan Grover
Journal:  Nat Microbiol       Date:  2022-04-28       Impact factor: 30.964

6.  Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.

Authors:  Giovanni Barbara; Madhusudan Grover; Premysl Bercik; Maura Corsetti; Uday C Ghoshal; Lena Ohman; Mirjana Rajilić-Stojanović
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

Review 7.  Mechanism-Oriented Therapy of Irritable Bowel Syndrome.

Authors:  Juan R Malagelada; Carolina Malagelada
Journal:  Adv Ther       Date:  2016-04-30       Impact factor: 3.845

8.  Evidence for long-term sensitization of the bowel in patients with post-infectious-IBS.

Authors:  D Balemans; S U Mondelaers; V Cibert-Goton; N Stakenborg; J Aguilera-Lizarraga; J Dooley; A Liston; D C Bulmer; P Vanden Berghe; G E Boeckxstaens; M M Wouters
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

9.  Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome.

Authors:  Seung Young Kim; Rok Seon Choung; Seung Ku Lee; Jung Wan Choe; Sung Woo Jung; Jong Jin Hyun; Ja Seol Koo; Sang Woo Lee; Chol Shin
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

10.  Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey.

Authors:  Tim Card; Paul Enck; Giovanni Barbara; Guy Ee Boeckxstaens; Javier Santos; Fernando Azpiroz; Fermin Mearin; Qasim Aziz; John Marshall; Robin Spiller
Journal:  United European Gastroenterol J       Date:  2018-05-23       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.